REVIEW
Published on 17 Jun 2026
Reconceptualizing glioblastoma immunotherapy: a four-pillar framework to overcome multidimensional resistance
doi 10.3389/fmed.2026.1848364
- 928 views
- Frontiers in Medicine
- Gene and Cell Therapy
- Research Topics
- Gene and Cell Therapy, a Therapeutic Promise for the Future: Successes and Limits
Gene and Cell Therapy, a Therapeutic Promise for the Future: Successes and Limits
2,045
Total downloads
16k
Total views and downloads
Articles
CASE REPORT
Published on 16 Jun 2026
Case Report: Similar STR profiles in non-twin siblings complicating chimerism analysis after allogeneic hematopoietic stem cell transplantation
doi 10.3389/fmed.2026.1863294
- 903 views
ORIGINAL RESEARCH
Published on 14 May 2026
HOPX is required for the generation of umbilical cord blood-derived memory-like NK cells induced by three cytokines
doi 10.3389/fimmu.2026.1808687
- 1,173 views
ORIGINAL RESEARCH
Published on 07 May 2026
RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H
doi 10.3389/fmed.2026.1813362
- 1,465 views
CASE REPORT
Published on 04 May 2026
Case Report: Intravenous transplantation of autologous adipose tissue-derived mesenchymal stem cells attenuated atopic dermatitis
doi 10.3389/fmed.2026.1831398
- 1,076 views
ORIGINAL RESEARCH
Published on 29 Apr 2026
rAAV9 vector biodistribution in nonhuman primate brain and spinal cord following lumbar intrathecal infusion
doi 10.3389/fmed.2026.1819594
- 1,977 views
ORIGINAL RESEARCH
Published on 15 Apr 2026
POLR2J knockdown promotes ROS-induced DDR and ferroptosis by inhibiting the STAT3-GPX4 signaling axis in LUAD
doi 10.3389/fonc.2026.1787943
- 964 views
ORIGINAL RESEARCH
Published on 15 Apr 2026
Clinical safety and tolerability of in vivo gene editing drug ART001 for ATTR amyloidosis
doi 10.3389/fmed.2026.1783921
- 1,678 views
ORIGINAL RESEARCH
Published on 14 Apr 2026
Spectrum and prognosis of CAR-T-related endocrine toxicity: glucose/calcium dysregulation, pituitary axis disorders, and overlap with CRS
doi 10.3389/fmed.2026.1786129
- 1,048 views
- 2 citations
ORIGINAL RESEARCH
Published on 07 Apr 2026
Zanubrutinib-based regimen as the salvage or bridging treatment of CART therapy in relapsed or refractory, non-germinal center B-cell–like diffuse large B-cell lymphoma: a retrospective multicenter cohort study
doi 10.3389/fimmu.2026.1806191
- 1,497 views
REVIEW
Accepted on 17 Jul 2026
Delivery Platforms for In Vivo CAR-T Engineering
Published in
Frontiers in Medicine
Gene and Cell Therapy
Other participating journals
Frontiers in Immunology
- 7.0 impact factor
- 11.3 citescore
Frontiers in Oncology
- 3.4 impact factor
- 6.6 citescore